The clinical impact of beta-blocker therapy after percutaneous coronary intervention for chronic total occlusion (CTO) is not well established. So we evaluated the clinical influence of beta-blocker therapy on percutaneous… Click to show full abstract
The clinical impact of beta-blocker therapy after percutaneous coronary intervention for chronic total occlusion (CTO) is not well established. So we evaluated the clinical influence of beta-blocker therapy on percutaneous coronary chronictotal occlusion intervention. This retrospective analysis
               
Click one of the above tabs to view related content.